These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 12460321

  • 1. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R, Gunczler P, Esaa S, Weisinger JR.
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):725-30. PubMed ID: 12460321
    [Abstract] [Full Text] [Related]

  • 2. Decreased trabecular bone mineral density in children with idiopathic short stature: normalization of bone density and increased bone turnover after 1 year of growth hormone treatment.
    Lanes R, Gunczler P, Weisinger JR.
    J Pediatr; 1999 Aug; 135(2 Pt 1):177-81. PubMed ID: 10431111
    [Abstract] [Full Text] [Related]

  • 3. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H, Bjarnason R, Wirént L, Albertsson-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G.
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):617-24. PubMed ID: 11894973
    [Abstract] [Full Text] [Related]

  • 4. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
    Sartorio A, Conte G, Conti A, Masala A, Alagna S, Rovasio P, Faglia G.
    J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
    [Abstract] [Full Text] [Related]

  • 5. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults.
    Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J.
    Clin Endocrinol (Oxf); 1998 May; 48(5):561-8. PubMed ID: 9666867
    [Abstract] [Full Text] [Related]

  • 6. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults.
    Välimäki MJ, Salmela PI, Salmi J, Viikari J, Kataja M, Turunen H, Soppi E.
    Eur J Endocrinol; 1999 Jun; 140(6):545-54. PubMed ID: 10377504
    [Abstract] [Full Text] [Related]

  • 7. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 8. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.
    Kotzmann H, Riedl M, Bernecker P, Clodi M, Kainberger F, Kaider A, Woloszczuk W, Luger A.
    Calcif Tissue Int; 1998 Jan; 62(1):40-6. PubMed ID: 9405732
    [Abstract] [Full Text] [Related]

  • 9. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H, Riedl M, Pietschmann P, Schmidt A, Schuster E, Kreuzer S, Kainberger F, Frisch H, Geyer G, Hörl WH, Mayer G, Luger A.
    J Nephrol; 2004 Jan; 17(1):87-94. PubMed ID: 15151263
    [Abstract] [Full Text] [Related]

  • 10. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R.
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [Abstract] [Full Text] [Related]

  • 11. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
    Rahim A, Holmes SJ, Adams JE, Shalet SM.
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413
    [Abstract] [Full Text] [Related]

  • 12. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-blind placebo-controlled study with open follow-up.
    Finkenstedt G, Gasser RW, Höfle G, Watfah C, Fridrich L.
    Eur J Endocrinol; 1997 Mar; 136(3):282-9. PubMed ID: 9100553
    [Abstract] [Full Text] [Related]

  • 13. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
    Crofton PM, Stirling HF, Schönau E, Kelnar CJ.
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
    [Abstract] [Full Text] [Related]

  • 14. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M, Fukunaga M, Ohtawa T, Harada T.
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult-onset GH deficiency: results from two 12-month randomized studies.
    Abrahamsen B, Hangaard J, Horn HC, Hansen TB, Gregersen G, Hansen-Nord M, Vahl N, Junker P, Andersen M, Hagen C.
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):273-81. PubMed ID: 12153608
    [Abstract] [Full Text] [Related]

  • 16. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus.
    Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR.
    J Pediatr Endocrinol Metab; 2001 May; 14(5):525-8. PubMed ID: 11393573
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD.
    Baroncelli GI, Bertelloni S, Sodini F, Saggese G.
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):175-84. PubMed ID: 14725678
    [Abstract] [Full Text] [Related]

  • 18. Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.
    Sartorio A, Ortolani S, Galbiati E, Conte G, Vangeli V, Arosio M, Porretti S, Faglia G.
    J Endocrinol Invest; 2001 Apr; 24(4):224-30. PubMed ID: 11383908
    [Abstract] [Full Text] [Related]

  • 19. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
    Boot AM, Nauta J, de Jong MC, Groothoff JW, Lilien MR, van Wijk JA, Kist-van Holthe JE, Hokken-Koelega AC, Pols HA, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
    [Abstract] [Full Text] [Related]

  • 20. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty.
    Boot AM, De Muinck Keizer-Schrama S, Pols HA, Krenning EP, Drop SL.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):370-3. PubMed ID: 9467543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.